Resources

In this exclusive interview transcript, Dr. Handelsman discusses the relationship between diabetes and cardiovascular disease, and the impact new diabetes drugs are having on management of both conditions.

In part 1 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about his work as an endocrinologist, and about why diabetes is a cardiovascular disease.

In part 2 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about changing diabetes guidelines and what we've learned through studies of new diabetes drugs.

In part 3 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about why the ACP changed A1C guidelines to 7% in their 2018 recommendations, and why he believes the new guideline is influenced by outdated research.

In part 4 of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about Heart in Diabetes program and the World Congress on Insulin Resistance.

In part 5, the conclusion of this Exclusive Interview, Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about possible future breakthroughs in diabetes devices and therapies.

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.

Use of expanded criteria thought best way to detect widest population with abnormal blood glucose levels.

It can improve insulin sensitivity, pancreatic response to blood sugars, and even prevent prediabetes from turning into diabetes.

ADA Guidelines highlight importance of social stability in diabetes management.